Cardiac lymphoma with early response to chemotherapy: A case report and review of the literature

J Nucl Cardiol. 2022 Dec;29(6):3044-3056. doi: 10.1007/s12350-021-02570-5. Epub 2021 Mar 11.

Abstract

Cardiac tumors are rare and benign masses account for the most part of the diagnosis. When malignant cancer is detected, primary or secondary cardiac lymphoma are quite frequent. Cardiac lymphoma may present as an intra or peri-cardiac mass or, rarely, it may diffusely infiltrate the myocardium. Although often asymptomatic, patients can have non-specific symptoms. Acute presentations with cardiogenic shock, unstable angina, or acute myocardial infarction are also described. Modern imaging techniques can help the clinicians not only in the diagnostic phase but also during administration of chemotherapy. A multidisciplinary counseling and serial multi-parametric assessment (echocardiography, cardiac troponin) seem to be the most effective approach to prevent possible fatal complications (i.e., cardiac rupture). Currently, only chemo- and radiotherapy are available options for treatment, but the prognosis remains poor. This is a case of secondary cardiac lymphoma presenting as a mediastinal mass with large infiltration of the heart and the great vessels with a good improvement after only one cycle of chemotherapy. It demonstrates the importance of an early diagnosis to modify the natural history of the disease.

Keywords: Basic science; diseases/processes; modalities; technical.

Publication types

  • Case Reports
  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Heart Neoplasms* / diagnostic imaging
  • Heart Neoplasms* / drug therapy
  • Heart Neoplasms* / pathology
  • Humans
  • Lymphoma* / diagnostic imaging
  • Lymphoma* / drug therapy
  • Myocardial Infarction*
  • Myocardium / pathology
  • Prognosis